Lymphoma, Large B-Cell, Diffuse

"Lymphoma, Large B-Cell, Diffuse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Descriptor ID	D016403
MeSH Number(s)	C04.557.386.480.150.585 C15.604.515.569.480.150.585 C20.683.515.761.480.150.585
Concept/Terms	Lymphoma, Large B-Cell, Diffuse Lymphoma, Large B-Cell, Diffuse Diffuse, Large B-Cell, Lymphoma Histiocytic Lymphoma Histiocytic Lymphomas Lymphomas, Histiocytic Histiocytic Lymphoma, Diffuse Diffuse Histiocytic Lymphoma Diffuse Histiocytic Lymphomas Histiocytic Lymphomas, Diffuse Lymphoma, Diffuse Histiocytic Lymphomas, Diffuse Histiocytic Large Lymphoid Lymphoma, Diffuse Lymphoma, Large-Cell, Diffuse Lymphoma, Diffuse Large-Cell Lymphoma, Diffuse Large Cell Lymphoma, Histiocytic Lymphoma, Large Lymphoid, Diffuse Lymphoma, Histiocytic, Diffuse Lymphoma, Large Cell, Diffuse Diffuse Large-Cell Lymphoma Diffuse Large Cell Lymphoma Diffuse Large-Cell Lymphomas Large-Cell Lymphomas, Diffuse Lymphomas, Diffuse Large-Cell Large-Cell Lymphoma, Diffuse Large Cell Lymphoma, Diffuse

Below are MeSH descriptors whose meaning is more general than "Lymphoma, Large B-Cell, Diffuse".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, B-Cell [C04.557.386.480.150]
Lymphoma, Large B-Cell, Diffuse [C04.557.386.480.150.585]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, B-Cell [C15.604.515.569.480.150]
Lymphoma, Large B-Cell, Diffuse [C15.604.515.569.480.150.585]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, B-Cell [C20.683.515.761.480.150]
Lymphoma, Large B-Cell, Diffuse [C20.683.515.761.480.150.585]

Below are MeSH descriptors whose meaning is related to "Lymphoma, Large B-Cell, Diffuse".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Large B-Cell, Diffuse".

Lymphoma, Large B-Cell, Diffuse
Plasmablastic Lymphoma

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, Large B-Cell, Diffuse" by people in this website by year, and whether "Lymphoma, Large B-Cell, Diffuse" was a major or minor topic of these publications.

Bar chart showing 13 publications over 12 distinct years, with a maximum of 2 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2005	1	0	1
2008	1	0	1
2009	0	1	1
2010	0	1	1
2011	1	0	1
2012	1	1	2
2016	1	0	1
2017	1	0	1
2018	1	0	1
2019	1	0	1
2021	1	0	1

Below are the most recent publications written about "Lymphoma, Large B-Cell, Diffuse" by people in Profiles.

Gupta A, Lee JA, Nguyen SA, Lentsch EJ. Primary diffuse large B-cell lymphoma of the major salivary glands: Increasing incidence and survival. Am J Otolaryngol. 2021 May-Jun; 42(3):102938.

View in: PubMed
Hayat M, Syed TA, Disbrow M, Tran NTB, Asad ZUA, Tierney WM. Recurrent Pancreatitis Secondary to Diffuse Large B Cell Lymphoma. J Gastrointest Cancer. 2019 Dec; 50(4):1009-1013.

View in: PubMed
Parker PA, Banerjee SC, Matasar MJ, Bylund CL, Rogers M, Franco K, Schofield E, Li Y, Levin TT, Jacobsen PB, Astrow AB, Leventhal H, Horwitz S, Kissane D. Efficacy of a survivorship-focused consultation versus a time-controlled rehabilitation consultation in patients with lymphoma: A cluster randomized controlled trial. Cancer. 2018 12 01; 124(23):4567-4576.

View in: PubMed
Salat H, Din NU, Moatter T, Kayani N, Ahmed A. Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience. Pathol Res Pract. 2017 Jun; 213(6):649-653.

View in: PubMed
Park SI, Grover NS, Olajide O, Asch AS, Wall JG, Richards KL, Sobol AL, Deal AM, Ivanova A, Foster MC, Muss HB, Shea TC. A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma. Br J Haematol. 2016 Oct; 175(2):281-289.

View in: PubMed
Cherry MA, Bhardwaj H, Hopps S, Srour S, Pant S. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report. J Oncol Pharm Pract. 2013 Sep; 19(3):261-4.

View in: PubMed
Fung KM, Chakrabarty JH, Kern WF, Magharyous H, Gehrs BC, Li S. Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient. Int J Clin Exp Pathol. 2012; 5(5):448-54.

View in: PubMed
Holter JL, Thorp K, Smith ML, Kedzierska K, Fung KM, Chacko G, Swisher K, Epstein R, Gumerlock MK. [18F]fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma. Cancer Imaging. 2011 Sep 24; 11:140-3.

View in: PubMed
Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010 Aug; 63(2):292-308.

View in: PubMed
Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L, Iyadurai K, Becker N, Brooks-Wilson A, Curry JD, Spinelli JJ, Holly EA, Riby J, Zhang L, Nieters A, Smith MT, Brown KM. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet. 2009 Aug; 41(8):873-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals